WASHINGTON — A key Senate committee on Wednesday voted to require drug companies to justify price hikes to the federal government if they exceed 10% in a year or 25% in a three-year span, advancing a proposal that also enjoys bipartisan support in the House.
The measure, spearheaded by Sen. Tammy Baldwin (D-Wis.), was offered as an amendment to a broader health care bill being considered by the Senate’s Health, Education, Labor, and Pensions Committee. Three other senators — two Republicans and one Democrat — co-sponsored the legislation, which the committee voted to include by a 16-7 margin.
About the Author Reprints
